Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”)...
Diagnostics
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”)...
DiagnosTear Technologies Inc. – Confirmation of No Material Change
Vancouver, British Columbia--(Newsfile Corp. - December 9, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"),...
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
SALT LAKE CITY, Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with...
Medit Launches AuraVue: A Unified 3D Intraoral Scan and X-Ray Visualization Powered by Overjet AI
NEWPORT BEACH, Calif., Dec. 9, 2025 /PRNewswire/ -- Medit, a global leader in 3D intraoral scanning and digital dentistry solutions,...
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
BOSTON, Dec. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Deep Origin on a 4.5-year project...
Lunai Bioworks Identifies Three Parkinson’s Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market
SACRAMENTO, Calif., Dec. 9, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotechnology company developing precision therapeutics, today announced...
Abbott’s Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
Lingo, Abbott's first over-the-counter biowearable, expands to Android devicesContinuous glucose monitoring devices help people maintain healthy glucose levels, which are...
Astrin Biosciences Announces Scientific Advisory Board to Advance Early Cancer Detection Leveraging AI and Proteomics
Board includes internationally recognized physicians and scientists from Dana-Farber Cancer Institute, George Washington University, Mayo Clinic, Montefiore Einstein Comprehensive Cancer...
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings,...
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to...
The Dot Corp Partners with ixlayer to Advance Direct-to-Patient Kitting & Fulfillment for Biopharma
IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp, a leader in high quality print, kitting, assembly, and fulfillment for...
November in Review: 10 Top Health Press Releases
A roundup of the most newsworthy healthcare press releases from PR Newswire, including new company mergers, Alzheimer's fundraising and advances...
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary...
GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models
AI-Driven Risk Prediction for Breast, Prostate and Pancreatic CancersTOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese Name:...
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
Extends cash runway into first half of 2028, beyond planned completion of ViraxImmune™ US based regulatory study in post-acute sequelae of...
Korea University Researchers Create Hydrogel Platform for High-Throughput Extracellular Vesicle Isolation
A meso–macroporous hydrogel enables rapid, scalable extracellular vesicle isolation from diverse biofluids without preprocessing stepsSEOUL, South Korea, Dec. 4, 2025...
TriageLogic Expands Global Health Access in Emerging Markets With Core Clinical Decision Support
TriageLogic's scalable triage intelligence anchors a new model for community-level care in Africa and South America. JACKSONVILLE, FL / ACCESS...
Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN...
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
AUSTIN, Texas, Dec. 04, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Chronic illnesses and rare disorders among older Americans represent...